 |
市場調査レポート
商品コード
1321959
除細動器の世界市場 - 市場規模、シェア、成長分析：タイプ別、最終用途別 - 産業予測（2023年～2030年）Global Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type(implantable cardioverter defibrillators, external cardioverter defibrillators), By End use(hospitals, pre-hospital) - Industry Forecast 2023-2030 |
||||||
| 除細動器の世界市場 - 市場規模、シェア、成長分析：タイプ別、最終用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年07月12日
発行: SkyQuest
ページ情報: 英文 224 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の除細動器の市場規模は、2021年の111億9,000万米ドルから2030年までに208億米ドルに達し、予測期間（2023年～2030年）にCAGRで7.2％の成長が予測されています。
市場は、世界の心血管疾患の流行に牽引され、安定した成長を示しています。技術の進歩や早期診断・治療オプションに対する意識の向上が、市場の拡大をさらに促進しています。植込み型除細動器（ICD）や体外式除細動器に対する需要の高まりは、市場の将来が有望であることを示しています。
促進要因
除細動器は、コスト削減、小型化、使いやすさにおいて大きく進歩しています。技術の進歩には、自動体外式除細動器（AED）や植込み型除細動器（ICD）の開発が含まれます。これらの機器は心臓疾患の管理に非常に有効です。除細動器の技術の進歩に伴い、機器の操作が訓練を受けた人にとってより簡単になりました。
抑制要因
除細動器のコストは、特に低所得層の患者にとって大きな障壁となります。さらに、医療の予算が限られているため、将来的にはこれらの機器の普及率が低下する可能性があります。
動向
スマートペースメーカーは、心機能のわずかな不規則性さえ検出できる革新的な機器です。心臓の異常に対処し、正常な身体機能を回復させます。さらに、患者の心臓の健康状態について、患者と医師の両方に警告を与えます。スマートペースメーカーのこの機能は、死亡率の減少に貢献しています。
当レポートでは、世界の除細動器市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の除細動器市場：タイプ別
- 市場の概要
- 植込み型除細動器
- 体外式除細動器
世界の除細動器市場：最終用途別
- 市場の概要
- 病院
- 入院前
- パブリックアクセス市場
- 代替ケア
- 家庭
世界の除細動器の市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Koninklijke Philips N.V.
- LivaNova PLC
- Microport Scientific Corporation
- Nihon Kohden Corporation
- Progetti Srl
- Schiller AG
- Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)
- Stryker Corporation
- Defibtech, LLC
- Cardiac Science Corporation
- Physio-Control International (a subsidiary of Stryker Corporation)
- CU Medical Systems, Inc.
- Fukuda Denshi Co., Ltd.
- Mindray Medical International Limited
- Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc. )
- Cardionet (a subsidiary of BioTelemetry, Inc. )
Global Cardioverter Defibrillator Device market size was valued at USD 11.19 billion in 2021 and is poised to grow to USD 20.8 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).
The global market for cardioverter defibrillator devices is witnessing steady growth, driven by the rising prevalence of cardiovascular diseases worldwide. These devices play a crucial role in the prevention of sudden cardiac arrests by detecting irregular heart rhythms and delivering electric shocks to restore normal heartbeats. Technological advancements and increasing awareness about early diagnosis and treatment options are further fueling market expansion. The growing demand for implantable cardioverter defibrillators (ICDs) and external defibrillators indicate a promising future for the global cardioverter defibrillator device market.
Top-down and bottom-up approaches were used to estimate and validate the size of Cardioverter Defibrillator Device and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
Cardioverter Defibrillator Device market is segmented based on the Products, Technology, End User and region. Based on the Products, the Cardioverter Defibrillator Device market is segmented into software and services. Based on the technology, the Cardioverter Defibrillator Device Market has been segmented into Web based software, Cloud based software. Based on end users Cardioverter Defibrillator Device Market is segmented into Hospitals, Clinics, Ambulatory Surgery Centre, Diagnostic Centres and Others. Based on Region Cardioverter Defibrillator Device Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Driver
Defibrillators have made significant advancements in terms of cost reduction, size reduction, and ease of use. The technological progress includes the development of automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs). These devices are highly effective in managing cardiac conditions. With the advancements in defibrillator technology, operating the device has become simpler for trained individuals.
Restrain
The cost of cardioverter defibrillators poses a significant barrier, particularly for patients from low-income backgrounds. Additionally, limited healthcare budgets may result in a lower adoption rate of these devices in the future.
Trend
A smart pacemaker is an innovative device capable of detecting even the slightest irregularities in heart function. It addresses abnormalities in the heart and restores normal bodily functions. Furthermore, it provides alerts to both patients and physicians regarding the patient's cardiac health. This feature of the smart pacemaker contributes to reducing mortality rates.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Cardioverter Defibrillator Device Market by Type
- Market Overview
- implantable cardioverter defibrillators
- external cardioverter defibrillators
- Global Cardioverter Defibrillator Device Market by End use
- Market Overview
- hospitals
- pre-hospital
- public access market
- alternative care
- home
- Global Cardioverter Defibrillator Device Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microport Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Progetti Srl
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Schiller AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Defibtech, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Physio-Control International (a subsidiary of Stryker Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CU Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fukuda Denshi Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mindray Medical International Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardionet (a subsidiary of BioTelemetry, Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
